Document Page: First | Prev | Next | All | Image | This Release | Search
File: 102596_sep96_decls3_0013.txt
Subject: PERSIAN GULF GENERAL INFORMATION
Unit: VAR. BUMED
Parent Organization: BUMED
Box ID: BX303811
Folder Title: VARIOUS NAVAL MESSAGES FOLDER 1
Document Number: 3
Folder SEQ #: 2
Immune Globulin (IG) for Hepatitis A is not routinely
recommended for brief (several days) port visits in urban or
tourist areas. one can minimize exposure to Hepatitis A by
avoiding potentially contaminated water or food. Drinking water
(and beverages with ice) of unknown purity, uncooked or partially
cooked shellfish, and uncooked fruits or vegetables which are not
peeled or prepared by the traveler should be avoided.
Immune globulin (gamma globulin) is recommended, however,
for those whose travel is outside usual tourist routes, those who
may be unavoidably exposed to food or drinking water in settings
of questionable sanitation (ex. certain local hosted parties),
those who will be in contact with local young children in
settings of poor sanitation, and to those who will be in-country
for prolonged periods (several weeks). For such travelers, a
single dose of IG prophylaxis of .02 ml/Kg (approx. two (2) cc
deep intramuscular injection for the average adult) is recom-
mended for travel less than three (3) months. For longer periods
of travel, a different dosage, as well as other unrelated
preventive medicine concerns, must be addressed and can be
provided by NEPMU-7.
6. Malaria
Low to moderate risk. The predominant species is Plasmodium
vivax, with P. falciparum and P. malariae also being occasionally
reported. Malaria risk exists from Mar-Nov in rural areas of the
provinces of Sistan-Baluchistan and Hormozgan, the southern parts
of the governorates of: Fars, Kohgiluyeh-Boyar, Lorestan, and
Chahar Mahal-Bakhtiani, and the north of Khuzestan. Risk exists
below the altitude of 1500 meters. No urban risk is reported.
An increased incidence of malaria was reported in 1989. Approx-
n the south (south
of the Zagros Mountains, along the Persian Gulf) and in the
southeast (Sistan-Baluchistan), vectored by Anopheles stephensis
in the south and An. culicifacies in the southeast (AFMIC, DOW
31 JAN 90). Chloroquine resistance reported. Chloroquine resis-
tance is suspected on the southeastern border with Afghani-
stan/Pakistan based on unconfirmed clinical reports. The
presence of Mefloquine resistance is suspected.
No Chemoprophylaxis needed for routine urban port visit. For
other types of visits contact NEPMU-7. Personal protective
measures (such as proper clothing, DEET, and bed nets) should
always be stressed.
medical Department personnel should review the laboratory and
clinical diagnosis of malaria, as well as treatment. An adequate
supply of treatment drugs such as Fansidar, Quinine, and/or
Mefloquine should be readily available. A recommended reference
is the Navy Medical Department Guide to Malaria Prevention and
Control.
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 16 f:/Week-37/BX303811/VARIOUS NAVAL MESSAGES FOLDER 1/persian gulf general information:1018961450014
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-37
Box ID = BX303811
Unit = VAR. BUMED
Parent Organization = BUMED
Folder Title = VARIOUS NAVAL MESSAGES FOLDER 1
Folder Seq # = 2
Subject = PERSIAN GULF GENERAL INFORMATION
Document Seq # = 3
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 18-OCT-1996